DVA (DaVita) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DVA DaVita Inc DVA
91 GF Score
Price $183.86
GF Value $196.07
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is DaVita Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

DaVita's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $557 Mil. DaVita's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $12,850 Mil. DaVita's annualized EBITDA for the quarter that ended in Jun. 2026 was $2,997 Mil. DaVita's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 4.47.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for DaVita's Debt-to-EBITDA or its related term are showing as below:

DVA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.3   Med: 4.8   Max: 5.75
Current: 4.84

During the past 13 years, the highest Debt-to-EBITDA Ratio of DaVita was 5.75. The lowest was 3.30. And the median was 4.80.

DVA's Debt-to-EBITDA is ranked worse than
76.76% of 482 companies
in the Healthcare Providers & Services industry
Industry Median: 2.2 vs DVA: 4.84

DaVita  (NYSE:DVA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

DaVita Debt-to-EBITDA Related Terms

DaVita Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for DaVita's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Debt-to-EBITDA Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

DaVita Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

DVA vs EHC, UHS, ENSG: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, DaVita's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DaVita Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where DaVita's Debt-to-EBITDA falls into.


DVA
91GF Score
DaVita Inc DVA
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

DaVita's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(734.625 + 12339.646) / 2652.063
=4.93

DaVita's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(556.665 + 12849.809) / 2996.96
=4.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is DaVita (DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be undervalued. The current stock price of $183.86 is trading 6.2% below its estimated GF Value™ of $196.07. GuruFocus considers DaVita to be Fairly Valued.

Key valuation signals for DVA:

  • Debt-to-EBITDA:
  • GF Value™: $196.07 vs. price of $183.86 (6.2% below fair value)
  • GF Score™: 91/100 with 6 warning signs

No single metric tells the full story. See the DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
91GF Score

Get the complete analysis for DVA

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$183.86
Price
$196.07
GF Value